“In the Know,” which debuts today, features our conversations with the people and personalities in biopharma who may be working behind the scenes.

Dan Budwick has spent every day of his 18-year career on the cutting edge of medical research, serving as a go-between for biopharma companies and the investors and journalists covering them.

Well, every day except a couple of months in the early 2000s when he wandered around New York’s Upper East Side, collecting restaurant menus for an internet company.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy